search
inflammation
Trends
- 1University of Arizona scientists develop drug candidate for vascular dementia●Vascular dementia has no approved treatments. U of A scientists hope to change that with an inflammation-fighting drug candidate.
University of Arizona scientists are working on an inflammation-fighting drug candidate aimed at vascular dementia, a condition that currently has no approved treatments. The research, announced by the university, targets the inflammation believed to drive blood vessel-related cognitive decline. If successful, the candidate could become the first approved therapy for a disease affecting millions of older adults worldwide.
- 2AI detects retinal inflammation without dye at Retina Society 2026●Retina Society 2026: AI flags retinal inflammation without dye | Eye Care Network - Modern Retina
At the Retina Society 2026 meeting, researchers presented an artificial intelligence tool that can flag retinal inflammation without the need for fluorescein dye injections, according to coverage by Modern Retina and Ophthalmology Times. The dye-free approach could make diagnosing uveitis and similar conditions faster and more comfortable for patients, and ophthalmologists are weighing what it means for everyday retinal care.
- 3Case report explores microbiota-nutrition therapy for radiation proctitis●Microbiota-nutrition sequential therapy for refractory radiation proctitis: A case report
A newly published case report describes sequential therapy combining microbiota-based treatment and nutritional intervention for a patient with refractory radiation proctitis, a chronic rectal inflammation that can follow pelvic radiotherapy and often resists standard care. The report, published by Baishideng Publishing Group, adds to growing interest in targeting the gut microbiome and diet to manage hard-to-treat complications of cancer treatment, though it reflects a single patient's outcome.
- 4NIH grants $11.7 million for blood cancer inflammation research▼$11.7 million from NIH supports research on inflammation in blood cancers
The National Institutes of Health has awarded $11.7 million to WashU Medicine to support research into the role of inflammation in blood cancers. The funding will back studies exploring how inflammatory processes drive the development and progression of blood malignancies, work that could point to new treatment approaches for patients.
- 5Traditional Chinese medicine examined for inflammatory bowel disease treatment▼Targeting the Wnt/β-catenin pathway in inflammatory bowel disease: Mechanisms and challenges of traditional Chinese medicine treatment
A newly published review examines how traditional Chinese medicine may treat inflammatory bowel disease by targeting the Wnt/β-catenin signalling pathway, a key regulator of intestinal inflammation and repair. The paper outlines the proposed mechanisms of herbal compounds on this pathway and discusses the challenges that remain, including limited clinical evidence and the complexity of the signalling system, before such therapies can enter mainstream use.
- 6Hoffman to injured list with forearm inflammation, Culpepper recalled●Culpepper returns as Hoffman hits IL with forearm inflammation
A major league team has placed reliever Hoffman on the injured list with forearm inflammation and brought back Culpepper to fill his roster spot. Forearm issues in pitchers often raise concern about more serious elbow problems, so fans and analysts are watching closely for updates on how long Hoffman will be out.
- 7Study links depression and anxiety to heart disease via inflammation●Mediating effect of pro-inflammatory cytokines in the association between depression, anxiety, and cardiometabolic disorders in a multiethnic US population
A new study published in Nature examines a multiethnic US population and finds that pro-inflammatory cytokines may mediate the association between depression, anxiety, and cardiometabolic disorders such as heart disease and diabetes. The findings suggest inflammation could be a biological pathway explaining why mental health conditions raise the risk of metabolic and cardiovascular illness across diverse ethnic groups.